Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Costa Diagnostics AB
AB
Active
Org 5593449134
Rottnevägen 35
Hospital activities · NACE 8610
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 354K
+42% vs 2024
EBITDA margin
92.3%
+48% vs 2024
Equity ratio
67.1%
Financial strength
Net profit 2025
SEK 261K
+50% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 354K
+42%
EBITDA
SEK 326K
+48%
Net profit
SEK 261K
+50%
Total assets
SEK 481K
+35%
Equity
SEK 323K
+61%
Employees
1
—
Company information
Legal name
Costa Diagnostics AB
Org number
5593449134
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
8 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsulttjänst som specialistläkare inom radiologi
Contact
Address
Rottnevägen 35
Email
andreas.costa@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Hospital activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
275
166
248
354
Staff expenses
—
−5
−4
−10
EBITDA
248
140
221
326
Depreciation & amort.
—
—
—
—
EBIT
248
140
221
326
Net financials
−0
−0
−1
2
Profit before tax
248
139
220
328
Tax
−51
−29
−46
−67
Net profit
197
110
175
261
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
337
294
356
481
Equity
222
137
201
323
Long-term debt
—
—
—
4
Short-term debt
115
157
155
154
Total debt
115
157
155
158
Financial ratios
5-year trend
EBITDA margin
92.3%
This company
15.8%
Market median
+484% vs market
2022
2025
Equity ratio
67.1%
This company
38.2%
Market median
+76% vs market
2022
2025
Return on equity
81.0%
This company
18.4%
Market median
+340% vs market
2022
2025
Net profit margin
73.9%
This company
8.1%
Market median
+812% vs market
2022
2025
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
2022
2025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-11-08 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TS
Tanja Sanne M Van De Meulebrouck
Deputy Board Member
2022
AF
Andreas Filipe Oliveira E Costa
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Costa Diagnostics AB also hold positions in
0
other companies.
Person
Role here
Other companies
Tanja Sanne M Van De Meulebrouck
Deputy Board Member
0 companies
Andreas Filipe Oliveira E Costa
Board of Directors
0 companies